A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA

Effects of EpCAM overexpression on human breast cancer cell lines

(2011) Johanna M Gostner et al.   BMC CANCER

A Novel Fusion Toxin Derived from an EpCAM-Specific Designed Ankyrin Repeat Protein Has Potent Antitumor Activity

(2010) P. Martin-Killias et al.   CLINICAL CANCER RESEARCH

The Emerging Role of EpCAM in Cancer and Stem Cell Signaling

(2009) M. Munz et al.   CANCER RESEARCH

EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins

(2009) J. Winkler et al.   MOLECULAR CANCER THERAPEUTICS

Nuclear signalling by tumour-associated antigen EpCAM

(2009) Dorothea Maetzel et al.   NATURE CELL BIOLOGY

A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators

(2008) K Maaser et al.   BRITISH JOURNAL OF CANCER

TACE/ADAM-17: A Component of the Epidermal Growth Factor Receptor Axis and a Promising Therapeutic Target in Colorectal Cancer

(2008) N. B. Merchant et al.   CLINICAL CANCER RESEARCH